Develops cell-based therapies and regenerative solutions which advance personalized treatment and wellness applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
AiVita Biomedical develops advanced biotechnology solutions focused on regenerative medicine, cell-based therapies, and personalized immunotherapy approaches. It applies expertise in stem cell science and cellular engineering to create treatments and products that address complex health conditions and support therapeutic innovation. The company also extends its platform into consumer applications by developing science-driven skincare and wellness solutions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
AiVita Biomedical Management Team
AiVita Biomedical Valuations & Financials
View real-time NPM data on AiVita Biomedical stock including daily AiVita Biomedical stock price estimates, valuation history, and historical share price information. Access AiVita Biomedical financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track AiVita Biomedical pricing across six independent market signals. Looking for private company due diligence data sources on AiVita Biomedical? Get in touch to learn more.
Similar Companies
like AiVita Biomedical
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Claira
AI & Machine Learning
Uncovers hidden deal insights by transforming complex documents into structured data for smarter financial workflows.
Kitopi
Offers a scalable cloud kitchen platform that enables restaurants to expand their delivery operations without the need for additional locations.
Qunnect
Enterprise Software
Deploys entanglement-based quantum networking gear that enables secure, scalable connectivity over current fiber systems.
Nothing
Builds consumer tech that integrates hardware and software to deliver distinctive, design-led devices with a more expressive user experience.
Arine
Healthcare & Life Sciences
Optimizes medication to ensure each patient is on the safest, most effective therapy for their unique health needs.
Qsic
Optimizes physical brick-and-mortar storefront environments by executing automated in-store music curation and target advertisement scheduling.
Huntress
Cybersecurity
Provides managed detection, investigation, and response services tailored primarily for small and medium-sized businesses.
Valon
Delivers artificial intelligence software to automate mortgage servicing workflows and loan data management.
FAQ
We have answers
AiVita Biomedical stock does not trade on public stock exchanges. AiVita Biomedical stock is considered a private security and you need to be an accredited investor to trade shares. To invest in AiVita Biomedical stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
AiVita Biomedical Stock does not trade on public stock exchanges. In order to sell AiVita Biomedical shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
AiVita Biomedical does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view AiVita Biomedical share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for AiVita Biomedical stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell AiVita Biomedical stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in AiVita Biomedical stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
AiVita Biomedical is a private company and has not had an IPO. There is currently no AiVita Biomedical IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to AiVita Biomedical IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
